{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:51:47Z","timestamp":1789523507434,"version":"build-2803163510"},"reference-count":72,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BERING21AO"],"award-info":[{"award-number":["BERING21AO"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"published-print":{"date-parts":[[2023,4,3]]},"DOI":"10.1080\/17425255.2023.2220960","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T05:09:10Z","timestamp":1685596150000},"page":"203-216","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Drug-drug interactions involving CFTR modulators: a review of the evidence and clinical implications"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6696-3948","authenticated-orcid":false,"given":"Eunjin","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6939-039X","authenticated-orcid":false,"given":"Alan","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3744-3310","authenticated-orcid":false,"given":"Paul","family":"Beringer","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USA"},{"name":"USC Anton Yelchin CF Clinic, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200505-840OE"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0112-2019"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25627"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11060458"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03079-2020"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010023"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13329"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32597-8"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-015-0293-6"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2786"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.05.001"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(19)30552-1"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2017.09.006"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmer.2022.100972"},{"key":"cit0016","unstructured":"Flockhart D, Thacker D, McDonald C, et al. The flockhart cytochrome P450 drug-drug interaction table. Division of Clinical Pharmacology, Indiana University School of Medicine. [Updated 2021; cited .2022 29 Dec]. Available from: https:\/\/drug-interactions.medicine.iu.edu"},{"key":"cit0017","unstructured":"Food and Drug Administration, Table of Substrates, Inhibitors and Inducers [Updated 2022; cited 2022 Dec 29]. Available from: https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers."},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy6030091"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2008.09.007"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23505"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(92)90140-2"},{"key":"cit0022","unstructured":"U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Clinical Pharmacology and Biopharmaceutics review(s), Ivacaftor. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2012\/203188Orig1s000ClinPharmR.pdf"},{"key":"cit0023","unstructured":"U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Clinical Pharmacology and Biopharmaceutics review(s), Tezacaftor\/Ivacaftor. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/210491Orig1s000ClinPharmR.pdf."},{"key":"cit0024","unstructured":"U.S. Food and Drug Administration. Center for drug evaluation and research. Multi-Discipline review, Elexacaftor\/Tezacaftor\/Ivacaftor. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/212273Orig1s000MultidisciplineR.pdf"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8040094"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645010-00002"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1038\/86882"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2585"},{"key":"cit0029","volume-title":"Kalydeco [package insert]","year":"2020"},{"key":"cit0030","volume-title":"Symdeko [package insert]","year":"2022"},{"key":"cit0031","volume-title":"Trikafta [package insert]","year":"2021"},{"key":"cit0032","volume-title":"Orkambi [package insert]","year":"2022"},{"key":"cit0033","volume-title":"Center for drug evaluation and research Clinical Pharmacology And Biopharmaceutics Review(s)","author":"U.S. Food and Drug Administration"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.2174\/1872312812666180328105259"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.121829"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A208"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051438"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12499"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.377"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12090856"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01104-22"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2021.04.005"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13324"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207360"},{"issue":"2","key":"cit0045","first-page":"197","volume":"17","author":"Combalbert J","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/37.6.1111"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342090-00003"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23971"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100230"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2015.01.003"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.2174\/187231210791292717"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.028746"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1339-x"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1586\/ecp.13.4"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.305"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.2165\/11317220-000000000-00000"},{"key":"cit0057","volume-title":"Prograf [package insert]","year":"2022"},{"key":"cit0058","volume-title":"Zocor [package insert]","year":"2010"},{"key":"cit0059","unstructured":"Halcion [package insert]. [NY,(NY)]: Pfizer Inc; 2016."},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179866"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.075416"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.1.1.3.53600"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1124\/mol.114.094862"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.117.077834"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-020-00124-7"},{"key":"cit0066","unstructured":"Crixivan [prescribing information]. Merck & Co., Inc. 2018."},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1128\/aac.06282-11"},{"key":"cit0068","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department Of Health And Human Services. Department of Health and Human Services. 2022."},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200038020-00002"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.02.010"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.241497"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113195"}],"container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2023.2220960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T17:11:31Z","timestamp":1686849091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2023.2220960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,3]]}},"alternative-id":["10.1080\/17425255.2023.2220960"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2023.2220960","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-02-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}